3-iodobenzylguanidine has been researched along with serine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halldórsson, H; Jónsson, O; Kjeld, M; Thorgeirsson, G | 1 |
| Buongiorno, M; De la Cerda, A; Ezquerra, M; Gaig, C; Lomeña, F; Martí, MJ; Muxí, A; Navales, I; Paredes, P; Santacruz, P; Tolosa, E; Valldeoriola, F | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and serine
| Article | Year |
|---|---|
Inhibitory effects of meta-iodo-benzylguanidine (MIBG) on endothelial histamine receptor binding.
Topics: 3-Iodobenzylguanidine; Binding, Competitive; Cells, Cultured; Choline; Cyclic GMP; Cytidine; Endothelium, Vascular; Histamine; Histamine H1 Antagonists; Humans; Inositol; Iodobenzenes; Nitric Oxide; Phospholipids; Propranolol; Pyrilamine; Receptors, Histamine H1; Serine; Umbilical Veins | 1998 |
123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Glycine; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Radionuclide Imaging; Radiopharmaceuticals; Serine; Severity of Illness Index; Smell; Statistics, Nonparametric | 2011 |